COPD Trial, Recruiting (NCT07315958)

COPD Trial, Recruiting NCT07315958 Sponsor: AstraZeneca Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT07315958 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 40 years of age or older.
People with a smoking history of 10 pack-years or more (this means smoking roughly one pack of cigarettes per day for 10 years, or an equivalent amount over a different time period — confirm with trial site if unsure).
People who are willing and able to complete a breathing test using a device called a spirometer, which measures how well the lungs work.
People who have given written consent to take part in the study.
People who are already attending a heart (cardiology) clinic at one of the participating hospitals or medical centres.
People who are willing and able to complete a short questionnaire about breathing symptoms called the CAAT questionnaire.

Who may not be able to join:

People who have been diagnosed with bronchial asthma.
People who used a bronchodilator (a medication that opens up the airways) to treat an acute respiratory infection before having their breathing test done.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 1-877-240-9479

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07315958

Sponsor: AstraZeneca

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: 1-877-240-9479

More information: https://clinicaltrials.gov/study/NCT07315958

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 40 years of age or older.
People with a smoking history of 10 pack-years or more (this means smoking roughly one pack of cigarettes per day for 10 years, or an equivalent amount over a different time period — confirm with trial site if unsure).
People who are willing and able to complete a breathing test using a device called a spirometer, which measures how well the lungs work.
People who have given written consent to take part in the study.
People who are already attending a heart (cardiology) clinic at one of the participating hospitals or medical centres.
People who are willing and able to complete a short questionnaire about breathing symptoms called the CAAT questionnaire.

Who may not be able to join:

People who have been diagnosed with bronchial asthma.
People who used a bronchodilator (a medication that opens up the airways) to treat an acute respiratory infection before having their breathing test done.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

AstraZeneca

Registry

ClinicalTrials.gov

Start date

8 October 2025

Est. completion

30 September 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Prevalence (number and percentage) of outpatients attending cardiology clinics, with a history of smoking who exhibit concurrent AL consistent with COPD.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov